Keros Therapeutics Inc (KROS)
60.35
-2.72
(-4.31%)
USD |
NASDAQ |
Nov 14, 16:00
60.35
0.00 (0.00%)
After-Hours: 17:39
Keros Therapeutics Price: 60.35 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 65.04 | 65.93 | 62.07 | 63.07 | 329192.0 |
| Nov 12, 2024 | 67.13 | 68.64 | 64.38 | 64.88 | 547899.0 |
| Nov 11, 2024 | 67.91 | 70.26 | 67.89 | 68.15 | 422580.0 |
| Nov 08, 2024 | 67.22 | 68.41 | 65.54 | 67.91 | 624526.0 |
| Nov 07, 2024 | 66.30 | 70.00 | 65.60 | 67.17 | 372378.0 |
| Nov 06, 2024 | 65.00 | 66.99 | 63.76 | 66.45 | 535838.0 |
| Nov 05, 2024 | 60.00 | 62.93 | 59.47 | 62.58 | 322659.0 |
| Nov 04, 2024 | 59.63 | 61.49 | 57.53 | 59.95 | 448280.0 |
| Nov 01, 2024 | 58.50 | 60.14 | 58.14 | 59.94 | 351458.0 |
| Oct 31, 2024 | 59.48 | 59.60 | 57.79 | 58.04 | 507983.0 |
| Oct 30, 2024 | 59.75 | 60.92 | 59.08 | 59.64 | 266405.0 |
| Oct 29, 2024 | 60.72 | 60.72 | 58.98 | 60.14 | 251099.0 |
| Oct 28, 2024 | 61.52 | 62.68 | 60.73 | 60.73 | 310258.0 |
| Oct 25, 2024 | 60.00 | 61.87 | 59.94 | 60.76 | 258241.0 |
| Oct 24, 2024 | 58.66 | 59.86 | 58.33 | 59.56 | 366465.0 |
| Oct 23, 2024 | 59.09 | 60.25 | 57.95 | 57.99 | 189334.0 |
| Oct 22, 2024 | 59.79 | 60.56 | 58.99 | 59.33 | 137583.0 |
| Oct 21, 2024 | 60.83 | 61.22 | 59.44 | 60.30 | 266958.0 |
| Oct 18, 2024 | 61.28 | 61.38 | 59.99 | 61.25 | 340419.0 |
| Oct 17, 2024 | 61.78 | 62.22 | 60.58 | 61.09 | 293522.0 |
| Oct 16, 2024 | 61.21 | 62.52 | 59.60 | 62.18 | 613441.0 |
| Oct 15, 2024 | 60.90 | 61.40 | 59.61 | 60.39 | 401326.0 |
| Oct 14, 2024 | 59.38 | 61.52 | 58.71 | 60.50 | 369159.0 |
| Oct 11, 2024 | 57.65 | 59.88 | 56.95 | 59.78 | 224704.0 |
| Oct 10, 2024 | 57.27 | 58.05 | 56.79 | 57.79 | 266927.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
20.08
Minimum
Apr 08 2020
82.74
Maximum
Dec 17 2020
47.01
Average
46.84
Median
Price Benchmarks
| Eli Lilly and Co | 786.07 |
| Regeneron Pharmaceuticals Inc | 781.46 |
| Scholar Rock Holding Corp | 27.49 |
| NovaBay Pharmaceuticals Inc | 0.7276 |
| Palatin Technologies Inc | 1.07 |
Price Related Metrics
| PS Ratio | 3233.35 |
| PEG Ratio | -2.205 |
| Price to Book Value | 4.588 |
| Earnings Yield | -8.63% |
| Market Cap | 2.445B |
| PEGY Ratio | -2.205 |